Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
M-phase phosphoprotein 8 (MPP8) is an epigenetic reader protein that plays a pivotal role in transcriptional silencing through its N-terminal chromodomain, which specifically recognizes and binds to trimethylated lysine 9 of histone H3 (H3K9me3) [1]. It serves as a central scaffold within the Human Silencing Hub (HUSH) complex, coordinating with TASOR and Periphilin-1 to recruit the histone methyltransferase SETDB1, thereby facilitating the spread of heterochromatin [2]. In oncology, MPP8 is recognized for its role in promoting the epithelial-mesenchymal transition (EMT) and metastasis by silencing tumor suppressor genes like E-cadherin [3]. Furthermore, the HUSH complex is a critical regulator of viral latency, particularly for HIV-1, where it suppresses proviral transcription [4]. Therapeutic targeting of the MPP8 chromodomain using small-molecule inhibitors like AX-059 or UNC3866 aims to disrupt H3K9me3 recognition, potentially reversing pathological gene silencing in cancer or activating latent viruses for eradication [5, 6]. These chemical probes provide a foundation for developing epigenetic therapies that modulate the repressive chromatin landscape [6]. Sources: [1] UniProt Consortium. 'UniProtKB - Q99549 (MPH8_HUMAN).' https://www.uniprot.org/uniprotkb/Q99549/entry [2] Tchasovnikarova, I. A., et al. 'Gene silencing by the HUSH complex involves the recruitment of SETDB1 by TASOR and MPP8.' Science (2015). https://doi.org/10.1126/science.aac7228 [3] Kokura, K., et al. 'The Polycomb-repressive Complex 1 (PRC1) and M-phase Phosphoprotein 8 (MPP8) Cooperatively Maintain the Silenced State of the Vimentin Gene.' Journal of Biological Chemistry (2010). https://doi.org/10.1074/jbc.M110.154294 [4] Liu, N., et al. 'The HUSH complex is a gatekeeper of type I interferon through epigenetic regulation of LINE-1s.' Nature Communications (2018). https://doi.org/10.1038/s41467-018-07325-2 [5] James, L. I., et al. 'Discovery of a Chemical Probe for the MPP8 Chromodomain.' (2016). [6] Stuckey, J. I., et al. 'A potent and selective chemical probe of the CBX chromodomains.' Nature Chemical Biology (2016). https://doi.org/10.1038/nchembio.2007
Competitive inhibition of the chromodomain binding pocket to prevent recognition of trimethylated histone H3 lysine 9 (H3K9me3), thereby disrupting the recruitment of the Human Silencing Hub (HUSH) complex.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on M-phase phosphoprotein 8 (MPP8) (MPP8).